Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
Enter Symbol
Company
Overview
Research Notes
Company Profile
Competitors
Community
Wiki
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Related News
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
36M
Market Cap:
$1.16B
Avg Volume:
2405393
P/E Ratio:
-0.010
PEG Ratio:
-0.010
Split:
On 4/11/2003 rdea split by factor of 0.080
Trade now with
1m
3m
6m
1y
2y
Opinion and Analysis
U.S. Stocks Drop As Global Growth Worries Weigh; Hot Stocks: WMT, TXN, NFLX, COP, K, EAT, HAS, RDEA
Apr 23, 2012 04:47 PM |
COP
,
EAT
,
HAS
,
K
,
NFLX
,
RDEA
U.S. Stocks Poised For Sharply Lower Open; Hot Stocks: (WMT, COP, K, RDEA)
Apr 23, 2012 09:07 AM |
COP
,
K
,
RDEA
,
WMT
UBS Securities Initiates Ardea Biosciences (RDEA) As 'Buy', PT $31
Apr 12, 2012 01:28 PM |
RDEA
Top Insider Buy Stock: AUXL, NEOP, RDEA, PHM, MNKD
Sep 02, 2011 02:09 PM |
AUXL
,
MNKD
,
NEOP
,
PHM
,
RDEA
15 Stocks Ready For A Short Squeeze
Feb 07, 2011 08:19 PM |
AACC
,
CCBG
,
CMLS
,
CONN
,
CVBF
,
FFKT
More Articles on RDEA..
Market News
More News on RDEA..
Press Releases
Ardea Biosciences Announces First Quarter 2012 Financial Results
May 07, 2012 08:30 AM |
RDEA
Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Ardea Biosciences, Inc.
May 01, 2012 10:39 AM |
RDEA
The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Ardea Biosciences, Inc. in Connection With the Sale of the Company to AstraZeneca
Apr 26, 2012 04:03 PM |
RDEA
More Press Releases on RDEA..
SEC Filings
Form 4 Ardea Biosciences, Inc./ For: May 06 Filed by: DAVIS STEPHEN (10K)
May 07, 2012 07:37 PM
Form 3 Ardea Biosciences, Inc./ For: Apr 21 Filed by: ASTRAZENECA PLC (10K)
May 01, 2012 04:01 PM
Form 4 Ardea Biosciences, Inc./ For: Apr 25 Filed by: FUCHS HENRY J (10K)
Apr 26, 2012 07:30 PM
More SEC Filings on RDEA..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
RDEA
Compare to S&P
YTD
88.58 %
73.22 %
4 Weeks
49.60 %
50.98 %
12 Weeks
62.56 %
60.45 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-8.70 %
EPS Growth in Last Year:
-111.86 %
Sales Growth in Last Quarter:
-11.56 %
Sales Growth in Last Quarter:
-16.61 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##